You are here:
Home / Board of Trustees
Saturday, 04. February 2012
Board of Trustees
The Assmann Foundation's board of trustees:
- Prof. Dr. Andreas Busch
Member of the executive board, Bayer Schering Pharma AG, Berlin - Prof. Dr. Paul Cullen
Member of the executive board, Deutsche Infarktforschungshilfe e.V., Münster - Prof. Dr. Arnold von Eckardstein
Director, Institute of Clinical Chemistry, UniversitätsSpital, Zürich - Prof. Dr. Dr. mult. Fritz Kemper
Former director, Institute of Pharmacology, University Hospital of Münster - Jan Kleinewefers
Kleinewefers Verwaltungs GmbH, Krefeld - Dr. Klaus Kleinfeld
Chairman and Chief Executive Officer, Alcoa, New York.
Chairman of the Assmann Foundation's board of trustees - Achim Kolanoski
President, Deutsche BKK, Wolfsburg - Rainer-Christian Koppitz
CEO Industry, Energy & Healthcare, Siemens AG, Siemens IT Solutions and Services, München - Dr. Uwe Oberländer
Roche Diagnostics GmbH, Mannheim, Head of Marketing, Laboratory Diagnostics - Dr. Andreas Penk
Managing director, Pfizer Pharma GmbH, Berlin - Dr. Norbert Pyhel
Dep. CEO SCOR Global Life, Köln - Steffen Retzlaff
Hemopharm Pharmazeutisches Unternehmen GmbH, Bad Homburg - Dr. Helmut Schulte
Research associate, Leibniz-Institut für Arterioskleroseforschung an der Universität Münster - Prof. Dr. Ursel Wahrburg
Fachbereich Oecotrophologie, University of Applied Sciences, Münster